# OnCo record abenacianine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/abenacianine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "abenacianine" ;
  schema:name "Abenacianine"@en ;
  schema:alternateName "VGT-309"@en ;
  schema:description "Abenacianine is an experimental tumour-targeted fluorescent imaging agent from Vergent Bioscience, in phase 3 trials for lung cancer and lung metastases."@en ;
  schema:url <https://onco.cc/drugs/abenacianine/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.vergentbio.com/technology>, <https://www.vergentbio.com/>, <https://clinicaltrials.gov/study/NCT05400226>, <https://clinicaltrials.gov/search?intr=VGT-309> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Tumour-targeted fluorescent imaging agent (quenched activity-based probe)" ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/> ;
  onco:targets <https://onco.cc/targets/ctss/> ;
  onco:companies <https://onco.cc/companies/vergent-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct07499674/>, <https://onco.cc/trials/nct06145048/>, <https://onco.cc/trials/nct05400226/>, <https://onco.cc/trials/nct06034197/> .